Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 857 results for "mylan"

Mylan settles over generic Generess tablets and launches insomnia drug
Pharma Letter

Teva denied injunction

The U.S. Supreme Court Chief Justice John Roberts denies Teva's ( TEVA ) application for an injunction to prevent Mylan ( MYL ) from launching a generic version of Copaxone until the Court rules on the matter later this year. The ruling opens the ... Seeking Alpha, 8 hours ago

172 images for mylan

Pharma Letter, 4 days ago, 4 days ago
Drug Discovery and Development, 4 days ago
I Stock Analyst, 1 day ago
FTI Consulting, 3 days ago
Pharma Times, 2 weeks ago
Daily World, 4 days ago
Drug Discovery and Development, 4 days ago
Pharma Letter, 5 days ago
Bidness Etc, 2 weeks ago

Prosonix signs licensing agreement with Mylan

Prosonix, Ltd., a specialty pharmaceutical company, has entered into a global licensing agreement with Mylan, Inc. for its inhaled respiratory products, PSX1001 and PSX1050. Both the companies are based in the US. Mylan, Inc. is a pharmaceutical ...
 Individual.com3 days ago Prosonix enters into licensing agreement with Mylan  Individual.com4 days ago Prosonix partners with Mylan for global development and commercialisation of generic inhaled respiratory products  Individual.com4 days ago Prosonix, Mylan license agreement for generic versions of Flixotide and Flovent  Pharmaceutical Business Review3 days ago
Nordic Life Science

Mylan Considering Takeover of Sweden's Meda -FT

) has been banned for excessive usage. If you believe this was done in error, please email, and include in your email both your IP address as well as the URL you are trying
 RCR Wireless News1 week ago Mylan looking at takeover of Swedish drug maker Meda  RCR Wireless News1 week ago Meda Board Issues Statement Confirming Contact by Mylan, Rejection of Proposal  RCR Wireless News1 week ago Meda Turns Down Merger Offer From Mylan  Pharmaceutical Online1 week ago

Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines

LONDON On Wednesday, April 09, 2014 SOURCE Investor-Edg 11:35 ET 11:30 ET A Apr 09, 2014, 10:43 ET Visit for releases, photos, ProfNet experts, and customized feeds just for Media. View and download archived video content distributed by ...
 PR Newswire1 week ago

Mylan sues Celegene for blocking generic version of Revlimid, Thalomid

Mylan ( MYL ) has sued Celgene ( CELG ) over the what Mylan says are illegal actions that Celgene has taken to keep generic versions of its Revlimid and Thalomid blockbuster drugs off the market. Mylan wants to force Celgene to sell it enough ...
 Seeking Alpha2 weeks ago Mylan sues Celgene for blocking Revlimid, Thalomid generics  CNBC2 weeks ago Mylan sues Celgene over cancer drugs  Big News Network2 weeks ago
Nordic Life Science

Mylan may buy Swedish Meda

According to Financial Times, the US drug generic producer has set is eyes on taking over the Swedish rival Meda. The journal writes that Mylan hasappointed advisers to help it put together a deal for Meda, but that the deal is not yet ...
 Nordic Life Science1 week ago Generic drug maker Mylan may buy Swedish rival Meda - FT  Yahoo! Finance2 weeks ago Trade in Meda shares halted on Mylan bid reports  The Gulf Today2 weeks ago Mylan Inc. Rumored To Be Considering Bid For Swedish Pharm Rival Meda AB, Shares Halted  BioSpace2 weeks ago
Money Control

The twist in the trastuzumab tale

Roche challenges bio-similar versions of its breast cancer drug from Biocon and Mylan Mumbai, February 9: Swiss drug-maker Roche is not unfamiliar with being in the eye of a storm, especially over Herceptin, used in treating women with HER2-positive breast ...
 Business Line2 months ago HC ban on Biocon, Mylan cancer drug sale criticised  Economic Times2 months ago Roche gets break in case against India sales of cancer drug  Money Control2 months ago Roche sues Biocon, Mylan, DCGI over cancer drug  Economic Times2 months ago
Business Line

What made Gilead Sciences choose Mylan as India partner

Manufacturing capacity, quality and ethical approach proved winners February 11, 2014: Last month, California-based Gilead Sciences expanded its alliance with fellow multinational Mylan to bring its branded medicines into India. In an interview with PT Jyothi ...
 Business Line2 months ago Mylan to sell Gilead's branded drugs in India  Business Standard2 months ago Mylan is now Gileads branded medicine partner in India  Business Line2 months ago
Business Standard

Mylan launches first Trastuzumab biosimilar in India

Mylan Inc has launched the worlds first biosimilar version of breast cancer drug Trastuzumab, in India. The product, marketed by Mylan under the brand name HertrazTM, is a biosimilar of Roche's Herceptin, Mylan said, without details on how the drug is priced ...
 Business Line2 months ago Mylan launches breast cancer drug in India  Business Standard2 months ago Mylan launches first biosimilar for breast cancer in India  Business Standard2 months ago Mylan Launches World's First Trastuzumab Biosimilar in India  Med India2 months ago
Business Standard

Agila starts voluntary recall of anesthetic injection in US

Bangalore-based Strides has sold this business to Mylan for $1.6 billion BS Reporter | Bangalore February 21, 2014 Last Updated at 20:40 IST Mylan Inc this week announced that its subsidiary Agila Specialties Private Limited is conducting a voluntary ...
 Business Standard1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - mylan
Get updated on latest news & your favorite topics right in your inbox!
More     Less